TFRC
protein-codingtransferrin receptor, the group of M28 metallopeptidases|CD molecules
Gene summary
This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~69.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0014760
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014760
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014760
Submitter: ClinGen
TFRC was first reported in relation to autosomal recessive TFRC-related combined immunodeficiency in 2016 (Jabara et al., 26642240). Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Two missense variants have been reported in eight probands, in three publications (PMID 26642240, 32851577, 38270687). This variant segregated with disease in eight additional family members. Symptoms include recurrent sinopulmonary infections, chronic diarrhea, recurrent epistaxis secondary to thrombocytopenia, mild anemia, and immunodeficiency. Heterozygous carriers were reported to be unaffected. This gene-disease relationship is supported by murine models, functional alteration and rescue experiments in patient cells, in vitro assays showing the gene product performs a biochemical function consistent with the phenotype, and functional alteration in non-patient cells (PMID: 3568132, 6265934, 10192390, 26642240). Patient cells homozygous for the Y20H variant showed defective transferrin uptake and transduction of wild type TfR1 corrected defective transferrin uptake (PMID 26642240). TFRC null mice are embryonic lethal while Tfrc Y20H/Y20H mice had significantly decreased serum IgG, hemoglobin, and MCV compared to controls, as well as impaired receptor internalization on T and B cells (PMID: 26642240, 10192390). In summary, there is definitive evidence to support the relationship between TFRC and autosomal recessive TFRC-related combined immunodeficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the SCID-CID GCEP on October 13, 2022. It was re-evaluated on March 20, 2025. As a result of this reevaluation, the classification increased from Moderate to Definitive with the addition of a new case (PMIDs: 38270687).
Inheritance Pattern: AR
Disease ID:MONDO:0014760
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014760
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Hematologic
Intervention: Allergy/Immunology/Infectious
Rationale: The condition has been described as involving severe childhood-onset infections, and and awareness may allow preventive measures, and early and aggressive treatment of infections; HSCT has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TFRC variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001128148.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 148 | 5 | 159 | ||
| missense | 1 | 297 | 12 | 1 | 311 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 5 | 5 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 5 | 6 | |||
| Total | 1 | 1 | 313 | 160 | 6 | 481 |
Highest pathogenic variant AF is 0.0003295038
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001121620.1 | 18 | MANE Select | |
| Ensembl | ENSP00000353224.4 | 18 | MANE Select | |
| RefSeq | NP_001300894.1 | 16 | Standard | |
| RefSeq | NP_001300895.1 | 12 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| tfr1b | Danio rerio | Structure: post-vent region Quality: curved ventral abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- HIF-1 signaling pathway - Homo sapiens (human)
- Endocytosis - Homo sapiens (human)
- Phagosome - Homo sapiens (human)
- Hematopoietic cell lineage - Homo sapiens (human)
- Ferroptosis - Homo sapiens (human)
Biological Process
- regulation of cell growth
- iron ion transport
- cellular iron ion homeostasis
- osteoclast differentiation
- positive regulation of B cell proliferation
Molecular Function
- virus receptor activity
- RNA binding
- double-stranded RNA binding
- transferrin receptor activity
- protein binding
Cellular Component
- extracellular region
- extracellular space
- endosome
- early endosome
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000360110
- Coding exons
- 18
- Length
- 55007
- Individuals with no LoFs
- 125732
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 16
- Defined
- 125748
- p
- 0.0000636
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.605 | 380 | 415 | 0.916 | 0.0000220 | 4992 |
| Missense (PolyPhen) | 131 | 162.63 | 0.80549 | 1941 | ||
| Synonymous | -0.00406 | 155 | 155 | 1.00 | 0.00000877 | 1453 |
| Loss of Function | 3.58 | 14 | 37.7 | 0.371 | 0.00000178 | 492 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000063 | 0.000062 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000079 | 0.000079 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site. Positively regulates T and B cell proliferation through iron uptake (PubMed:26642240). {ECO:0000250, ECO:0000269|PubMed:26642240, ECO:0000269|PubMed:3568132}.;
- Disease
- DISEASE: Immunodeficiency 46 (IMD46) [MIM:616740]: An autosomal recessive primary immunodeficiency disorder characterized by early-onset chronic diarrhea, recurrent infections, hypo- or agammaglobulinemia, normal lymphocyte counts, intermittent neutropenia, and intermittent thrombocytopenia. {ECO:0000269|PubMed:26642240}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.799
Intolerance Scores
- LoFtool
- 0.531
- RVIS EVS
- -0.71
- RVIS percentile EVS
- 14.67
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.883
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |